|
Reference |
Supplier |
Description |
Unit |
Price excl. taxes |
|
|
|
EPY0000385 |
European Pharmacopoeia |
1,4-Sorbitan 50mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000386 |
European Pharmacopoeia |
Foeniculin for peak identification Star anise oil 100mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000387 |
European Pharmacopoeia |
Pseudoisoeugenyl 2-methylbutyrate for peak identification 100mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000388 |
European Pharmacopoeia |
Newcastle Disease Vaccine BRP TBC |
|
334.56 CHF
363.67 €
|
|
|
|
EPY0000389 |
European Pharmacopoeia |
Hepatitis B vaccine (rDNA) BRP method A (thiomersal free) TBC |
|
175.44 CHF
190.70 €
|
|
|
|
EPY0000390 |
European Pharmacopoeia |
Oxeladin impurity D 2-(2-diethylaminoethoxy)ethyl 2-phenyl-butyrate dihydrogen citrate 20mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000391 |
European Pharmacopoeia |
Betahistine dihydrochloride 50mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000392 |
European Pharmacopoeia |
Closantel sodium dihydrate 20mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000393 |
European Pharmacopoeia |
Closantel for system suitability 20mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000394 |
European Pharmacopoeia |
Dipivefrine for system suitability TBC |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000395 |
European Pharmacopoeia |
Granisetron impurity E (1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000396 |
European Pharmacopoeia |
Granisetron hydrochloride 120mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000397 |
European Pharmacopoeia |
Lysine acetate 60mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000398 |
European Pharmacopoeia |
Methyl nicotinate TBC |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000399 |
European Pharmacopoeia |
Naproxen (racemic) 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000400 |
European Pharmacopoeia |
Naltrexone hydrochloride 50mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000401 |
European Pharmacopoeia |
Pimobendan for system suitability 0.1mg |
|
157.76 CHF
171.49 €
|
|
|
|
EPY0000402 |
European Pharmacopoeia |
Pyrantel embonate 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000403 |
European Pharmacopoeia |
Pyrantel impurity A 1-methyl-2-[(Z)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyrim idine 20mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000404 |
European Pharmacopoeia |
Oxeladin impurity C 2-(diethylamino)ethyl 2-ethyl-2-phenylbutanoate 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000405 |
European Pharmacopoeia |
Salicylic acid impurity B 4-hydroxyisophthalic acid 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000406 |
European Pharmacopoeia |
Iopamidol impurity H 4-chloro-N,N'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-(2-hydroxypropanoyl)amino)2,6-diiodobenzenz-1,3-dicarboxamide 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000407 |
European Pharmacopoeia |
Methylrosanilinium Hydrochloride 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000408 |
European Pharmacopoeia |
Stavudine 100mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000409 |
European Pharmacopoeia |
Famotidine impurity D 3-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanamide 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000410 |
European Pharmacopoeia |
Naltrexone impurity C N-(3-butenyl)-noroxymorphone 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000412 |
European Pharmacopoeia |
Sulfamethoxazole impurity A N-(4-(5-methyl)-isoxazol-3-ylsulphamoyl)phenylacetamide 5mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000413 |
European Pharmacopoeia |
Sulfamethoxazole impurity F 4-amino-N-(3-methylisoxazol-5-yl)benznesulphonamide 5mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000414 |
European Pharmacopoeia |
Tiamulin for peak identification 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000415 |
European Pharmacopoeia |
Felypressine 0.994MG 0.994mg |
|
157.76 CHF
171.49 €
|
|
|
|
EPY0000416 |
European Pharmacopoeia |
Ranitidine impurity J 1,1'-N-[methylenebis(sulphanediylethylene)]bis(N'-methyl-2-nitroethene-1,1-diamine) *** 0.00025mg |
|
157.76 CHF
171.49 €
|
|
|
|
EPY0000417 |
European Pharmacopoeia |
Pentazocine lactate - reference spectrum TBC |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000418 |
European Pharmacopoeia |
Methylrosanilinium HCl (40mg) 40mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000419 |
European Pharmacopoeia |
Fludarabine phosphate 120mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000420 |
European Pharmacopoeia |
Cefotaxime acid 80 mg 20mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000421 |
European Pharmacopoeia |
Stavudine for system suitability TBC |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000422 |
European Pharmacopoeia |
Salmeterol xinafoate (40mg) 70mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000423 |
European Pharmacopoeia |
Salmeterol xinafoate for system suitability 25mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000424 |
European Pharmacopoeia |
Atracurium besilate 120mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000425 |
European Pharmacopoeia |
Lamivudine 150mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000426 |
European Pharmacopoeia |
Lamivudine for system suitability 2 10.3mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000427 |
European Pharmacopoeia |
Acarbose for peak identification 20mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000428 |
European Pharmacopoeia |
Methanol - reference spectrum ea |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000429 |
European Pharmacopoeia |
Trospium Chloride TBC |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000430 |
European Pharmacopoeia |
Trospium impurity C (1R,3r,5S)-3-hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium] 5mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000431 |
European Pharmacopoeia |
Trospium impurity B (1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl hydroxydiphenylacetate 20mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000432 |
European Pharmacopoeia |
Trospium impurity A Hydroxydiphenylacetic acid (benzilic acid) 20mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000433 |
European Pharmacopoeia |
Ammonium glycyrrhizate (70mg) 70mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000434 |
European Pharmacopoeia |
Boldine 30mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0000435 |
European Pharmacopoeia |
Captopril impurity E (S)-1-isobutyryl-pyrrolidine-2-carboxylic acid 15mg |
|
152.32 CHF
165.57 €
|
|
